Regenerative Outcomes for Peri-implant Bony Defects Using Amnion-chorion Barrier vs. Collagen Membrane

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorLoma Linda University

About this trial

The purpose of this study is to compare the clinical and radiographic outcomes of two different barrier membranes-amnion-chorion membranes (ACM) and conventional collagen membranes-used in guided bone regeneration (GBR) procedures for the treatment of peri-implantitis. Both membranes are commonly used in clinical practice; however, this study aims to determine whether ACM offers greater benefits in terms of peri-implant probing depth reduction, radiographic bone fill, and patient-reported post-operative healing outcomes. The findings may help inform surgical decision-making and support the use of ACM as a more effective regenerative material for managing peri-implant bony defects.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Systemically healthy adults (≥18 years) with a diagnosed peri-implantitis lesion requiring surgical intervention of any ethnicity

Comprehension of treatment plan and research project.

Presence of a single implant in function for at least one year.

Radiographic evidence of peri-implant bone loss not exceeding one-third of the implant length.

Disqualifiers

Patients who have had a history of periodontitis, diabetes, smoking habit, or have been prescribed medications that may interfere with bone healing and metabolism

Patients with allergies to any treatment devices

Patients who have a lack of keratinized mucosa (<2 mm), or positioning for implants or restorative designs that compromise oral hygiene

Peri-implant bone defects not attributable to peri-implantitis (e.g. surgical iatrogenic, trauma)

Trial design

Design model

Parallel

Treatments tested in this trial

  • BioXclude Amnion Chorion Membrane

    Device

    A resorbable allograft membrane derived from dehydrated human amnion and chorion tissue. The membrane is placed over peri-implant bony defects during guided bone regeneration to act as a biological barrier and promote tissue healing.

  • Collagen Membrane

    Device

    A resorbable xenograft membrane derived from porcine collagen. The membrane is placed over peri-implant bony defects during guided bone regeneration to support space maintenance and facilitate bone regeneration.

Treatment groups

56 Participants
are divided into 2 treatment groups
Group A: Amnion Chorion MembraneExperimental treatment 1 intervention
Group B: Collagen MembraneActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Peri-Implant Probing Depths

Mean reduction in peri-implant probing depth (in millimeters) measured using a standardized periodontal probe at six time points to assess clinical improvement following guided bone regeneration with either an amnion-chorion or collagen membrane.

Time frame
Baseline, 3, 6, 12, 18, and 24 months post-operatively

Secondary outcomes

1

Radiographic Bone Fill

Assessment of vertical bone fill (in millimeters) around the treated implant sites using standardized periapical radiographs taken at baseline and follow-up visits. Images will be analyzed using calibrated software.

Time frame
Over 2 years
2

PROMS

Patient-reported outcomes will be assessed using a standardized questionnaire evaluating pain, comfort, satisfaction, healing, and communication. All items are rated on a 4-point Likert-type scale: 1 = Poor, 2 = Fair, 3 = Good, 4 = Excellent. Higher scores indicate better outcomes. Two yes/no item captures presence of post-op symptoms (e.g., swelling, bleeding, comfort).

Time frame
Baseline, 3, 6, 12, 18, and 24 months post-operatively

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: